IBRX News and Press, ImmunityBio Inc. From 01/25/24

2024-01-25 14:20:00 ET Summary With a lead asset in advanced Phase-III testing, CG Oncology, which debuts Thursday on the NASDAQ, is one of the year’s most highly anticipated IPOs. The company’s lead drug targets a sizable addressable market (NMIBC) where there is an...

2024-01-22 11:54:46 ET More on highly-shorted stocks Spirit Airlines: Don't Join The Panic Spirit Airlines: Ch.11 Bankruptcy Could Be A Better Option To Save The Airline Assessing JetBlue Airways During A Time Of Significant Uncertainty Over Spirit Airlines Turmoil ...

2024-01-17 15:09:43 ET More on crowded shorts VinFast's Warm Reception In Contrast To Cold Shoulder Chinese EV Makers Are Getting ImmunityBio: Approval Likely Priced In, Yielding Mostly Risk For Would-Be Buyers Beyond Meat: No Path To Recovery VinFast Auto la...

2024-01-02 16:55:53 ET Gainers: Bloomin' Brands ( BLMN ) +6% . Arcutis Biotherapeutics ( ARQT ) +6% . Stronghold Digital Mining ( SDIG ) +5% . Longboard Pharmaceuticals ( LBPH ) +4% . Guardant Health ( GH ) +3% . Losers: ...

2024-01-02 06:11:57 ET More on ImmunityBio ImmunityBio: Approval Likely Priced In, Yielding Mostly Risk For Would-Be Buyers ImmunityBio: On The Verge, But With Many Questions Remaining ImmunityBio: The CRL Makes It Riskier Than Ever ImmunityBio gains as bladd...

2023-12-23 07:00:00 ET More on Carvana Carvana: Kicking The Can Down The Road Carvana's Controversial Journey: Why I'm Still Bullish Despite Debt Exchange, Carvana Is Still Not A Buy Auto retail stocks gain after better-than-feared earnings report from CarMax...

2023-12-22 04:16:14 ET Summary ImmunityBio is a late-stage biotech company focused on developing immunotherapy approaches for cancer treatment. The company's main product of interest is Anktiva, a fusion protein designed to stimulate an antitumor response in bladder cancer patient...

2023-11-22 17:09:08 ET Gainers: Aurora Innovation ( AUR ) +2% . Innodata  ( INOD ) +2% . The Vita Coco Company ( COCO ) +2% . Immunovant ( IMVT ) +2% . The RealReal ( REAL ) +2% . Losers: BioCryst Pharmaceuticals ( ...

ImmunityBio, Inc. ( NASDAQ: IBRX ), a clinical-stage immunotherapy company, announced today that the company will be participating in the 35 th Annual Piper Sandler Healthcare Conference, which is taking place in New York City, November 28-30, 2023. Details of the presentation can be ...

ImmunityBio Inc. (IBRX) is expected to report $-0.27 for Q3 2023